The genetic alterations responsible for NIFTP include RAS oncogene alterations, similar to those driving follicular adenoma and follicular carcinoma tumors, in contrast to the BRAF oncogenes mutated in the classic papillary thyroid cancer pathway [2]. Here, BRAF is linked to thyroid gland papillary carcinoma.